Tag Archives: ALS

University of Helsinki: neuroprotective protein CDNF entered clinical trials on Parkinson’s disease patients

HELSINKI, 14-Aug-2017 — /EuropaWire/ — With the help of the two-year Therapeutic Idea Award from the US Department of Defense professor Saarma and Dr. Voutilainen aim to generate more preclinical data i.e. data from tests preceding the patient trials, to support … Read the full press release